BIO-TECHNE Corp (TECH)

Sentiment-Signal

21,4
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
35.5
0 neu, 1 erhöht, -8160843K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (11.02.2026)
DatumMeldungSchwereFilingAuszug
11.02.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi
04.03.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoint
05.02.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECt forth by specific reference in such filing. ​ Item 5.02 Departure of Directors or Certain Officers; Election of Direct
05.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECn 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoint
30.04.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin
08.01.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin
19.10.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin
31.01.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act. ☐ ​   ​ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi

Stammdaten

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Unternehmen & Branche

NameBIO-TECHNE Corp
TickerTECH
CIK0000842023
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP09073M104
ISINUS09073M1045
TypCommon Stock
Marktkapitalisierung9,48 Mrd. USD
Beta1,49
Dividendenrendite0,32 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-Q295,877,00038,009,0000.242,522,699,0002,010,989,000
2025-09-3010-Q286,555,00038,185,0000.242,526,148,000
2025-06-3010-K1,219,635,00073,400,0000.462,557,868,000
2025-03-3110-Q316,181,00022,588,0000.142,644,259,0002,018,025,000
2024-12-3110-Q297,031,00034,890,0000.222,670,424,0002,078,492,000
2024-09-3010-Q289,458,00033,600,0000.212,736,017,0002,138,650,000
2024-06-3010-K1,159,060,000168,105,0001.052,703,867,0002,068,850,000
2024-03-3110-Q303,428,00049,059,0000.312,721,170,0002,014,375,000
2023-12-3110-Q272,598,00027,465,0000.172,730,753,0001,963,559,000
2023-09-3010-Q276,935,00050,993,0000.312,755,360,0001,997,746,000
2023-06-3010-K1,136,702,000285,263,0001.762,638,692,0001,966,516,000
2023-03-3110-Q294,146,00070,218,0000.432,599,696,0001,889,686,000
2022-12-3110-Q271,581,00050,005,0000.312,363,401,0001,827,106,000
2022-09-3010-Q269,655,00089,555,0000.552,350,721,0001,751,154,000
2022-06-3010-K1,105,599,000272,051,0001.662,294,805,0001,701,770,000
2022-03-3110-Q290,376,00060,739,0000.372,299,892,0001,714,376,000
2021-12-3110-Q269,276,00080,173,0000.492,304,846,0001,702,989,000
2021-09-3010-Q257,719,00069,615,0001.692,270,187,0001,639,365,000
2021-06-3010-K931,032,000140,410,0000.872,262,957,0001,562,971,000
2021-03-3110-Q243,552,00045,782,0001.122,084,642,0001,539,453,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
VANGUARD GROUP INC17,810,878017,810,8781,047,457,735Neu+100,0%
BlackRock, Inc.12,129,125012,129,125713,313,819Neu+100,0%
MORGAN STANLEY8,345,41408,345,414490,794,044Neu+100,0%
STATE STREET CORP5,812,03205,812,032341,805,602Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP5,734,04905,734,049337,219,422Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC4,929,80104,929,801289,502,286Neu+100,0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4,012,81804,012,818235,993,825Neu+100,0%
MAVERICK CAPITAL LTD3,850,92303,850,923226,472,782Neu+100,0%
Invesco Ltd.3,678,65903,678,659216,341,937Neu+100,0%
Neuberger Berman Group LLC3,129,33403,129,334184,036,113Neu+100,0%
Select Equity Group, L.P.2,837,14202,837,142166,852,321Neu+100,0%
AMERIPRISE FINANCIAL INC2,798,43702,798,437164,576,211Neu+100,0%
MACKENZIE FINANCIAL CORP2,414,16502,414,165142,444,643Neu+100,0%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2,398,26502,398,265141,041,965Neu+100,0%
ALLIANCEBERNSTEIN L.P.2,364,84502,364,845139,076,534Neu+100,0%
UBS Group AG2,224,26302,224,263130,808,907Neu+100,0%
RGM Capital, LLC2,152,05202,152,052126,562,178Neu+100,0%
Durable Capital Partners LP2,088,89102,088,891122,847,680Neu+100,0%
AMERICAN CENTURY COMPANIES INC1,928,48501,928,485113,414,203Neu+100,0%
DIMENSIONAL FUND ADVISORS LP1,794,29301,794,293105,523,778Neu+100,0%
GOLDMAN SACHS GROUP INC1,692,84201,692,84299,556,044Neu+100,0%
NORGES BANK1,691,78001,691,78099,493,582Neu+100,0%
Capital Research Global Investors1,618,88201,618,88295,206,450Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,559,14401,559,14491,693,259Neu+100,0%
BROWN ADVISORY INC1,544,52801,544,52890,833,688Neu+100,0%
Champlain Investment Partners, LLC1,403,76901,403,76982,555,655Neu+100,0%
NORTHERN TRUST CORP1,332,20001,332,20078,346,682Neu+100,0%
BAMCO INC /NY/1,207,49901,207,49971,013,016Neu+100,0%
Madison Asset Management, LLC1,181,30801,181,30869,472,749Neu+100,0%
BANK OF AMERICA CORP /DE/1,137,31501,137,31566,885,517Neu+100,0%
Stephens Investment Management Group LLC1,109,65801,109,65865,258,987Neu+100,0%
GENEVA CAPITAL MANAGEMENT LLC1,090,49501,090,49564,132,012Neu+100,0%
Quantinno Capital Management LP1,019,34201,019,34259,947,524Neu+100,0%
FMR LLC1,014,96101,014,96159,689,871Neu+100,0%
WESTFIELD CAPITAL MANAGEMENT CO LP994,3300994,33058,476,547Neu+100,0%
CITADEL ADVISORS LLC984,4200984,42057,893,740Neu+100,0%
Clearbridge Investments, LLC948,5120948,51255,782,010Neu+100,0%
WEITZ INVESTMENT MANAGEMENT, INC.802,9500802,95047,221,490Neu+100,0%
RIVERBRIDGE PARTNERS LLC785,7880785,78846,212,174Neu+100,0%
JPMORGAN CHASE & CO759,0820759,08244,641,657Neu+100,0%
RAYMOND JAMES FINANCIAL INC746,8010746,80144,046,954Neu+100,0%
PRINCIPAL FINANCIAL GROUP INC703,4770703,47741,372,740Neu+100,0%
Ceredex Value Advisors LLC688,3210688,32140,480,158Neu+100,0%
DEUTSCHE BANK AG\684,0090684,00940,226,570Neu+100,0%
ROYCE & ASSOCIATES LP678,5020678,50239,902,703Neu+100,0%
CRAMER ROSENTHAL MCGLYNN LLC654,4700654,47038,489,381Neu+100,0%
Caption Management, LLC562,4000562,40033,074,744Neu+100,0%
ROYAL BANK OF CANADA557,5290557,52932,788,000Neu+100,0%
TUDOR INVESTMENT CORP ET AL518,1290518,12930,471,166Neu+100,0%
SEGALL BRYANT & HAMILL, LLC486,0090486,00928,582,176Neu+100,0%

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-02-17Herr Amy E.DirectorOpen Market Sale-1,97659.11-116,791.48-22,3%
2025-08-25BAUMGARTNER ROBERT VDirectorOpen Market Sale-17,04056.21-957,818.40-182,6%
2025-08-25Nusse RoelandDirectorOpen Market Sale-17,04056.36-960,388.03-183,0%
2025-06-09Herr Amy E.DirectorOpen Market Sale-1,28049.77-63,704.83-12,1%

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-3198.05152,045.102.574
2026-03-3061950,9531.538
2026-03-273.43752,70181.130
2026-03-2623252,6912.224
2026-03-2531252,4316.358
2026-03-2438152,0019.812
2026-03-231.53251,4878.867
2026-03-209.46451,59488.248
2026-03-1723.08348,811.126.681
2026-03-1115852,828.346
2026-03-101.94354,87106.612
2026-03-092053,891.078
2026-03-0643.85755,892.451.168
2026-03-0319.94857,821.153.393
2026-02-2511.83857,60681.869
2026-02-2365357,5237.561

Top-Fondshalter

Stand: 31.03.2026

FondsAnteileWert (USD)Anteil (%)
GAGNON SECURITIES LLC9,879516,27759.63
OPPENHEIMER & CO INC5,132268,19830.98
West Financial Advisors, LLC1,55681,3179.39

Hinweis

Erweitert ×